TRANSLUTION CAPITAL ADVISES BLUE EQUITY
Posted on 2. June 2022
Translution Capital advises Blue Equity on the add-on acquisition of MME Nordic A/S
TRANSLUTION CAPITAL ADVISES MEDTRACE PHARMA
Posted on 31. May 2022
Translution Capital acted as financial advisor to Medtrace Pharma A/S in relation to their tranche II capital raise led by ATP, BankInvest and Swisscanto
BAWAT WATER TECHNOLOGIES’ OFFERING IS COMPLETE
Posted on 7. April 2022
The IPO will be carried out as a new issue of Units securing Bawat Water Technologies AB a transaction proceed of up to SEK 56.7 million. Translution Capital acted as exclusive financial advisor to Bawat Water Technologies AB and is pleased to congratulate CEO Marcus P. Hummer and the full Bawat Water Technologies AB team with this successful transaction. The IPO proceeds will allow the Company to make the most of the momentum they already are experiencing and further strengthen their international sales and marketing presence – a journey we are excited to follow.
Translution Capital Advises Bawat Water Technologies
Posted on 28. February 2022
Translution Capital advises Bawat Water Technologies on the forthcoming IPO on Nasdaq First North Premier
TRANSLUTION CAPITAL ADVISES MOSCORD PTE.LTD
Posted on 10. February 2022
Translution Capital advises Moscord Pte.Ltd in securing their new funding round
JAKOB SCHMIDT NEW PARTNER AT TRANSLUTION CAPITAL
Posted on 7. February 2022
We are pleased to announce that our Head of ECM, Jakob Schmidt, has been named Partner at Translution Capital
SIGURD LILIENFELDT IS JOINING THE TRANSLUTION CAPITAL TEAM
Posted on 6. February 2022
We are very pleased to announce that Sigurd Lilienfeldt is joining Translution Capital as a Partner to further support the next chapter in Translution Capital’s growth journey
Translution Capital advises I Am Drinks
Posted on 11. January 2022
Translution Capital acted as financial advisor to the selling shareholders of I Am Drinks ApS on the trade sale of the company
Translution Capital advises Diok Real Estate
Posted on 23. November 2021
Translution Capital acted as financial advisor to Diok Real Estate AG securing a funding package of EUR 11 million
Translution Capital advises CombiGene (publ.)
Posted on 13. October 2021
Translution Capital advices CombiGene AB (publ.) on a deal securing a total funding package of up to SEK 509 million from Spark Therapeutics, a company within the Roche Group. We congratulate the CombiGene AB team on this successful deal.